Last updated: 6 March 2023 at 11:42am EST

Roger Tung Net Worth




The estimated Net Worth of Roger D Tung is at least $11.1 Million dollars as of 6 January 2023. Roger Tung owns over 9,240 units of Concert Pharmaceuticals Inc stock worth over $8,127,421 and over the last 11 years he sold CNCE stock worth over $234,158. In addition, he makes $2,772,350 as President, Chief Executive Officer, Co-Founder, and Director at Concert Pharmaceuticals Inc.

Roger Tung CNCE stock SEC Form 4 insiders trading

Roger has made over 16 trades of the Concert Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 9,240 units of CNCE stock worth $66,898 on 6 January 2023.

The largest trade he's ever made was exercising 60,000 units of Concert Pharmaceuticals Inc stock on 22 May 2014 worth over $67,800. On average, Roger trades about 8,531 units every 90 days since 2014. As of 6 January 2023 he still owns at least 971,018 units of Concert Pharmaceuticals Inc stock.

You can see the complete history of Roger Tung stock trades at the bottom of the page.





Roger Tung biography

Dr. Roger D. Tung Ph.D. serves as President, Chief Executive Officer, Co-Founder, Director of the Company. He is our scientific founder and has served as our President and Chief Executive Officer and as a member of our Board since April 2006. Before founding Concert, Dr. Tung was a founding scientist at Vertex Pharmaceuticals Incorporated, a pharmaceutical company, where he was employed from 1989 to 2005, most recently as its Vice President of Drug Discovery. Prior to Vertex, he held various positions at Merck, Sharp & Dohme Research Laboratories, a global healthcare provider, and The Squibb Institute for Medicinal Chemistry. During the last five years, Dr. Tung previously served on the board of directors of Flex Pharma, Inc. Dr. Tung received a B.A. in Chemistry from Reed College and a Ph.D. in Medicinal Chemistry from the University of Wisconsin-Madison. Tung’s detailed knowledge of Concert and his long career in the global pharmaceutical and biotechnology industries, including his roles at Vertex, make him a key contributor to our Board.

What is the salary of Roger Tung?

As the President, Chief Executive Officer, Co-Founder, and Director of Concert Pharmaceuticals Inc, the total compensation of Roger Tung at Concert Pharmaceuticals Inc is $2,772,350. There are no executives at Concert Pharmaceuticals Inc getting paid more.



How old is Roger Tung?

Roger Tung is 60, he's been the President, Chief Executive Officer, Co-Founder, and Director of Concert Pharmaceuticals Inc since 2006. There are 9 older and 6 younger executives at Concert Pharmaceuticals Inc. The oldest executive at Concert Pharmaceuticals Inc is Peter Hutt, 85, who is the Independent Director.

What's Roger Tung's mailing address?

Roger's mailing address filed with the SEC is C/O CONCERT PHARMACEUTICALS, INC., 65 HAYDEN AVENUE, SUITE 3000N, LEXINGTON, MA, 02421.

Insiders trading at Concert Pharmaceuticals Inc

Over the last 11 years, insiders at Concert Pharmaceuticals Inc have traded over $69,766,120 worth of Concert Pharmaceuticals Inc stock and bought 1,926,078 units worth $25,219,472 . The most active insiders traders include Plc Gsk, Associates Gp Llcqvt Fund V..., and Partners L P/Ilbiotechnolog.... On average, Concert Pharmaceuticals Inc executives and independent directors trade stock every 28 days with the average trade being worth of $447,820. The most recent stock trade was executed by Nancy Stuart on 15 February 2023, trading 6,048 units of CNCE stock currently worth $50,380.



What does Concert Pharmaceuticals Inc do?

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert's lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates.



What does Concert Pharmaceuticals Inc's logo look like?

Concert Pharmaceuticals Inc logo

Complete history of Roger Tung stock trades at Concert Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
6 Jan 2023 Roger D Tung
Chief Executive Officer
Sale 9,240 $7.24 $66,898
6 Jan 2023
971,018
15 Feb 2022 Roger D Tung
Chief Executive Officer
Sale 13,480 $3.09 $41,653
15 Feb 2022
980,258
6 Jan 2022 Roger D Tung
Chief Executive Officer
Sale 9,240 $3.09 $28,552
6 Jan 2022
784,838
13 Dec 2021 Roger D Tung
Chief Executive Officer
Option 6,700 $3.50 $23,450
13 Dec 2021
815,278
17 Feb 2021 Roger D Tung
Chief Executive Officer
Sale 13,480 $7.20 $97,056
17 Feb 2021
808,578
13 Mar 2020 Roger D Tung
Chief Executive Officer
Option 14,601 $3.79 $55,338
13 Mar 2020
752,758
4 Dec 2019 Roger D Tung
Chief Executive Officer
Option 13,166 $4.41 $58,062
4 Dec 2019
644,686
23 Apr 2019 Roger D Tung
Chief Executive Officer
Option 14,601 $3.79 $55,338
23 Apr 2019
631,520
10 Apr 2019 Roger D Tung
Chief Executive Officer
Option 24,886 $4.41 $109,747
10 Apr 2019
616,919
5 Mar 2018 Roger D Tung
Chief Executive Officer
Option 27,757 $4.58 $127,127
5 Mar 2018
650,855
17 Nov 2017 Roger D Tung
Chief Executive Officer
Option 7,340 $4.58 $33,617
17 Nov 2017
626,305
11 May 2016 Roger D Tung
Chief Executive Officer
Buy 19,610 $10.55 $206,886
11 May 2016
538,965
11 Jan 2016 Roger D Tung
Chief Executive Officer
Option 18,000 $4.58 $82,440
11 Jan 2016
519,355
11 Jan 2016 Roger D Tung
Chief Executive Officer
Option 18,000 $4.58 $82,440
11 Jan 2016
519,355
17 Feb 2015 Roger D Tung
Chief Executive Officer
Option 28,495 $1.13 $32,199
17 Feb 2015
490,017
22 May 2014 Roger D Tung
Chief Executive Officer
Option 60,000 $1.13 $67,800
22 May 2014
461,522


Concert Pharmaceuticals Inc executives and stock owners

Concert Pharmaceuticals Inc executives and other stock owners filed with the SEC include: